Kewaunee Scientific (NASDAQ:KEQU) Stock Rating Lowered by StockNews.com

Kewaunee Scientific (NASDAQ:KEQUGet Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Sunday.

Kewaunee Scientific Price Performance

Shares of Kewaunee Scientific stock opened at $42.54 on Friday. The firm has a market capitalization of $122.09 million, a PE ratio of 6.83 and a beta of 0.73. The business’s 50-day moving average price is $35.01 and its 200-day moving average price is $41.86. The company has a current ratio of 2.53, a quick ratio of 2.00 and a debt-to-equity ratio of 0.48. Kewaunee Scientific has a 12 month low of $16.51 and a 12 month high of $55.62.

Kewaunee Scientific (NASDAQ:KEQUGet Free Report) last posted its quarterly earnings results on Wednesday, September 11th. The technology company reported $0.93 earnings per share (EPS) for the quarter. The business had revenue of $48.39 million for the quarter. Kewaunee Scientific had a return on equity of 25.87% and a net margin of 9.13%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in KEQU. Dimensional Fund Advisors LP boosted its position in shares of Kewaunee Scientific by 3.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 177,548 shares of the technology company’s stock worth $8,378,000 after purchasing an additional 6,132 shares in the last quarter. Renaissance Technologies LLC raised its stake in Kewaunee Scientific by 13.4% during the second quarter. Renaissance Technologies LLC now owns 89,611 shares of the technology company’s stock valued at $4,230,000 after buying an additional 10,580 shares during the last quarter. De Lisle Partners LLP boosted its holdings in Kewaunee Scientific by 36.6% in the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock worth $1,446,000 after acquiring an additional 11,511 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Kewaunee Scientific by 8.9% in the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock worth $792,000 after acquiring an additional 1,941 shares during the last quarter. Finally, Ritholtz Wealth Management increased its holdings in shares of Kewaunee Scientific by 24.6% during the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock valued at $363,000 after acquiring an additional 2,156 shares in the last quarter. Hedge funds and other institutional investors own 32.69% of the company’s stock.

Kewaunee Scientific Company Profile

(Get Free Report)

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

Further Reading

Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.